Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie

Biologicals

Volumn 35, Issue 3, 2007, Pages 161-164

  Unal, A ^a   Thyer, J ^a   Uren, E ^a   Middleton, D ^b   Braun, M ^b   Maher, D ^a  

^a CSL Bioplasma   (Australia)

^b CSIRO   (Australia)

Author keywords

Bioassay; Inactivation; Prion; Scrapie; Sodium hydroxide

Indexed keywords

SODIUM HYDROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BRAIN HOMOGENATE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRAPIE; SCRAPIE AGENT; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BIOLOGICAL ASSAY; BIOLOGICAL PRODUCTS; CATTLE; DECONTAMINATION; MICE; PRPSC PROTEINS; SAFETY; SCRAPIE; SHEEP; SODIUM HYDROXIDE; TEMPERATURE;

MUS;

EID: 34249993477     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.08.003     Document Type: Article

References (19)

1. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., and Ironside J.W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
2. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
3. Health Protection Agency. New case of variant CJD associated with blood transfusion (2006). http://www.hpa.org.uk/hpa/news/articles/press_releases/2006/060209_cjd.htm
4. Kasermann F., and Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to proteinase K. J Gen Virol 84 (2003) 3173-3176
5. Tateishi J., Tashima T., and Kitamoto T. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immunol 35 (1991) 163-166
6. Taylor D.M., and Fernie K. Exposure to autoclaving or sodium hydroxide extends the dose-response curve of the 263K strain of scrapie agent in hamsters. J Gen Virol 77 (1996) 811-813
7. Reichl H.E., Foster P.R., Welch A.G., Li Q., MacGregor I.R., Somerville R.A., et al. Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin. Vox Sang 83 (2002) 137-145
8. Zobeley E., Flechsig E., Cozzio A., Enari M., and Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5 (1999) 240-243
9. Asher DM, Pomeroy KL, Murphy L, Gibbs CJ, Gajdusek DC. Attempts to disinfect surfaces contaminated with etiological agents of the spongiform encephalopathies. Seventh International Congress of Virology, Edmonton; 9-14 August 1987. p. 147.
10. Meyer R.K., McKinley M.P., Bowman K.A., Braunfeld M.B., Barry R.A., and Prusiner S.B. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 83 (1986) 2310-2314
11. Kozak R.W., Golker C.F., and Stadler P. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective. Dev Biol Stand 88 (1996) 257-264
12. Brown P., Rohwer R.G., and Gajdusek D.C. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 153 (1986) 1145-1148
13. Taylor D.M. Inactivation of the unconventional agents of scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. J Hosp Infect 18 Suppl. A (1991) 141-146
14. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15 (1996) 1255-1264
15. Finney D.J. Statistical methods in bioassay (1964), Charles Griffin and Co., London
16. Taylor D.M., Fraser H., McConnell I., Brown D.A., Brown K.L., Lamza K.A., et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 139 (1994) 313-326
17. Somerville R.A. TSE agent strains and PrP: reconciling structure and function. Trends Biochem Sci 27 (2002) 606-612
18. Taylor D.M. Inactivation of TSE agents: safety of blood and blood-derived products. Transfus Clin Biol 10 (2003) 23-25
19. Flechsig E., Hegyi I., Enari M., Schwarz P., Collinge J., and Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 7 (2001) 679-684